ANTIZYTOPLASMATISCHE ANTIKORPER ALS SEROMARKER UND AKTIVITATSPARAMETER DER WEGENERSCHEN GRANULOMATOSE. EINE PROSPKTIVE STUDIE

Translated title of the contribution: Anticytoplasmic antibodies as serological markers and markers of disease activity of Wegener's granulomatosis. A prospective study

G. Ludemann, B. Nolle, A. Rautmann, S. Rosenboom, J. Kekow, W. L. Gross

10 Citations (Scopus)

Abstract

Sera from 105 patients with Wegener's granulomatosis (WG) and 1,500 control subjects (with, among other diseases, primary or secondary vasculitis, collagen disease, glomerulonephritis or various granulomas) were examined with respect to sensitivity, specificity and importance of anticytoplasmic antibodies (ACPA) as markers of disease activity. The antibodies were demonstrated in 77 of the 105 patients (73%) with WG and six of the controls (< 1%). They were always present in active WG (57 patients). In a prospective study of 21 closely followed patients with WG there was a close correlation between ACPA titre and the disease activity as measured by clinical and biochemical criteria. After induction of remission there was in all instances a clear fall in titre, while the titre rose again on exacerbation but remained unchanged during superinfection. Thus anticytoplasmic antibodies are useful both in primary diagnosis and in estimating disease activity of WG.

Translated title of the contributionAnticytoplasmic antibodies as serological markers and markers of disease activity of Wegener's granulomatosis. A prospective study
Original languageGerman
JournalDeutsche Medizinische Wochenschrift
Volume113
Issue number11
Pages (from-to)413-417
Number of pages5
ISSN0012-0472
DOIs
Publication statusPublished - 1988

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Fingerprint

Dive into the research topics of 'Anticytoplasmic antibodies as serological markers and markers of disease activity of Wegener's granulomatosis. A prospective study'. Together they form a unique fingerprint.

Cite this